1
|
Soria A, Bernier C, Milpied B, Assier H, Castelain F, Amsler E, Barbaud A. Administration of an alternative iodinated contrast media in confirmed severe delayed hypersensitivity reactions. J Allergy Clin Immunol Pract 2024:S2213-2198(24)00279-4. [PMID: 38490579 DOI: 10.1016/j.jaip.2024.03.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Revised: 03/05/2024] [Accepted: 03/09/2024] [Indexed: 03/17/2024]
Affiliation(s)
- Angèle Soria
- Service de Dermatologie et Allergologie, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Médecine Sorbonne Université, Paris, France.
| | - Claire Bernier
- Service de Dermatologie et Plateforme Transversale d'Allergologie, Hôpital Hôtel Dieu, Nantes, France
| | | | - Haudrey Assier
- Service de Dermatologie, Hôpital Henri Mondor, Créteil, France
| | | | - Emmanuelle Amsler
- Service de Dermatologie et Allergologie, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Médecine Sorbonne Université, Paris, France
| | - Annick Barbaud
- Service de Dermatologie et Allergologie, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Médecine Sorbonne Université, Paris, France; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, Paris, France
| |
Collapse
|
2
|
Bocquel S, Soria A, Raison-Peyron N, Badaoui A, Marcant P, Bara C, Giordano-Labadie F, Amsler E, Milpied B, Delaunay J, Darrigade AS, Pralong P, Boulard C, Ferrier Le Bouedec MC, Tauber M, Pasteur J, Valois A, Le Thuaut A, Crépy MN, Bernier C. Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study. J Am Acad Dermatol 2024; 90:512-520. [PMID: 37871801 DOI: 10.1016/j.jaad.2023.10.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2023] [Revised: 10/13/2023] [Accepted: 10/17/2023] [Indexed: 10/25/2023]
Abstract
BACKGROUND Limited and conflicting data have been reported on the impact of dupilumab (DUPI) on patch test (PT) results and its efficacy against allergic contact dermatitis (ACD). OBJECTIVE This study was undertaken to analyze PT reactivities and relevance during treatment with DUPI to determine whether they could detect ACD in patients with uncontrolled or worsened atopic dermatitis (AD) who were receiving this agent. METHODS This prospective, multicenter study examined 76 DUPI-treated patients who had undergone PTs. The relevant information was collected during 3 visits. RESULTS Overall, 36 patients (47%) had ≥1 positive PT reaction, and 142 PT results were positive. Twenty-three patients (30%) had ≥1 positive and clinically relevant PT result. Five of them had clinical eczema improvement after allergen avoidance. We compared the PT results of 36 patients before and during DUPI therapy, representing 1230 paired PT allergens, of which 1022 were the same, 34 were positive, 44 were lost, and 130 were uninterpretable. LIMITATIONS Because the number of patients included remains limited, our findings should be confirmed with a larger sample. CONCLUSION Our results confirmed the usefulness of PTs for patients receiving DUPI, with good PT reproducibility. We suggest that all DUPI-treated patients with AD developing partial responses or experiencing symptom worsening should undergo PTs to look for contact sensitization.
Collapse
Affiliation(s)
- Sarah Bocquel
- Department of Dermatology, Nantes University Hospital, Nantes, France
| | - Angèle Soria
- Médecine Sorbonne Université, Service de Dermatologie et d'Allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Dermatology and allergy department, Tenon hospital, AP-HP, Paris, France
| | | | - Antoine Badaoui
- Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé, France
| | | | - Corina Bara
- Department of Dermatology, CH Le Mans, Le Mans, France
| | | | - Emmanuelle Amsler
- Médecine Sorbonne Université, Service de Dermatologie et d'Allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Dermatology and allergy department, Tenon hospital, AP-HP, Paris, France
| | - Brigitte Milpied
- Department of Dermatology, Hôpital Saint-André, Bordeaux, France
| | | | | | | | - Claire Boulard
- Department of Dermatology, CH Jacques-Monod, Le Havre, France
| | | | - Marie Tauber
- Department of Dermatology, CHU Toulouse, Toulouse, France
| | - Justine Pasteur
- Department of Dermatology, CHU Clermont-Ferrand, Clermont-Ferrand, France
| | - Aude Valois
- Department of Dermatology, HIA, Toulon, France
| | | | - Marie-Noëlle Crépy
- Department of Occupational and Environmental Diseases, Hôtel-Dieu Hospital, Paris, France
| | - Claire Bernier
- Department of Dermatology, Nantes University Hospital, Nantes, France.
| |
Collapse
|
3
|
Traineau H, Milpied B, Soria A, Assier H, Tetart F, Bernier C, Le Bouëdec MCF, Gener G, Kurihara F, Bauvin O, Delauney J, Amsler E, Bara C, Pelletier F, Valois A, Castelain F, de Risi Pugliese T, Hamelin A, Barbaud A. In Situ Patch Test and Repeated Open Application Test for Fixed Drug Eruption: A Multicenter Study. J Allergy Clin Immunol Pract 2024; 12:460-468. [PMID: 37863314 DOI: 10.1016/j.jaip.2023.10.021] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Revised: 09/26/2023] [Accepted: 10/10/2023] [Indexed: 10/22/2023]
Abstract
BACKGROUND Few studies have evaluated allergy workup in fixed drug eruption (FDE) in a large population. OBJECTIVE To evaluate the sensitivity of a standardized allergy workup for diagnosing the cause of FDE, with a focus on in situ repeated open application tests (ROATs). METHODS In a retrospective multicenter study, we analyzed the practice of conducting a complete allergy workup for the etiological diagnosis of FDE. It consisted of 3 steps: in situ patch tests (PTs) for all cases except pure mucosal involvement, followed by in situ ROAT if in situ PT results were negative, and finally a drug challenge (DC). The in situ ROAT involved daily application of the suspected drug on a previously affected FDE site for 7 days. RESULTS Of 98 suspected FDE cases, 61 patients (median age 61 y; male-to-female ratio 1.8) with a complete allergy workup were included. In 4 cases, even the DC yielded negative results. Among the remaining 57 patients with a positive workup, implicated drugs included paracetamol (12 cases), β-lactams (11 cases), imidazoles (9 cases, including 5 with metronidazole), nonsteroidal anti-inflammatory drugs (8 cases), iodinated contrast media (4 cases), cotrimoxazole (3 cases), and various other drugs in 10 patients. The diagnosis was confirmed by in situ PT in 17 of 54 cases (31.5%), in situ ROAT in 14 of 40 cases (35%) (with 4 cases showing remote reactivation of FDE sites), and DC in 26 cases. CONCLUSIONS The sequential allergy workup involving successively in situ PT, in situ ROAT, and DC is a reliable and safe method for diagnosing the cause of FDE. In situ tests exhibited a sensitivity of over 50%.
Collapse
Affiliation(s)
- Hélène Traineau
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Brigitte Milpied
- Centre hospitalo-universitaire (CHU) de Bordeaux, Dermatology department, Saint André hospital, Bordeaux, France
| | - Angèle Soria
- Cimi-Paris Inserm 1135, AP-HP, Sorbonne University, Hôpital Tenon, Dermatology and allergology department, Paris, France
| | - Haudrey Assier
- Dermatology department, AP-HP, Henri Mondor hospital, Créteil, France
| | | | | | | | - Gwendeline Gener
- Dermatology department, AP-HP, Henri Mondor hospital, Créteil, France
| | - Flore Kurihara
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | | | - Juliette Delauney
- CHU d'Angers, Dermatology department, Centre hospitalier de Cholet, Angers, France
| | - Emmanuelle Amsler
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Corina Bara
- Dermatology department, Centre hospitalier du Mans, Le Mans, France
| | | | - Aude Valois
- Dermatology department, Hôpital d'instruction des armées Sainte Anne, Toulon, France
| | | | - Tullia de Risi Pugliese
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Aurore Hamelin
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Annick Barbaud
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
| |
Collapse
|
4
|
Tzoumpa S, Brun S, Amsler E, Izri A, Akhoundi M, Caux F, Prost-Squarcioni C, Le Roux-Villet C. Bullous presentation of demodicosis in a young immunocompetent patient. Int J Dermatol 2024; 63:e6-e8. [PMID: 37990591 DOI: 10.1111/ijd.16930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Revised: 09/23/2023] [Accepted: 11/14/2023] [Indexed: 11/23/2023]
Affiliation(s)
- Sofia Tzoumpa
- Department of Dermatology, Reference Center for Auto-immune Bullous Diseases, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France
| | - Sophie Brun
- Parasitology-Mycology Department, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France
| | - Emmanuelle Amsler
- Department of Dermatology, Allergology and Vascular Medicine, Tenon University Hospital, AP-HP, Sorbonne University, Paris, France
| | - Arezki Izri
- Parasitology-Mycology Department, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France
- Unité des Virus Émergents, Aix Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection, Marseille, France
| | - Mohammad Akhoundi
- Parasitology-Mycology Department, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France
- Unité des Virus Émergents, Aix Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection, Marseille, France
| | - Frédéric Caux
- Department of Dermatology, Reference Center for Auto-immune Bullous Diseases, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France
| | - Catherine Prost-Squarcioni
- Department of Dermatology, Reference Center for Auto-immune Bullous Diseases, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France
| | - Christelle Le Roux-Villet
- Department of Dermatology, Reference Center for Auto-immune Bullous Diseases, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France
| |
Collapse
|
5
|
Litovsky J, Hacard F, Tétart F, Boccon-Gibod I, Soria A, Staumont-Sallé D, Doutre MS, Amsler E, Mansard C, Dezoteux F, Darrigade AS, Milpied B, Bernier C, Perrot JL, Raison-Peyron N, Paryl M, Droitcourt C, Demoly P, Grosjean J, Mura T, Du-Thanh A. Omalizumab Drug Survival in Chronic Urticaria: A Retrospective Multicentric French Study. J Allergy Clin Immunol Pract 2023; 11:3752-3762.e2. [PMID: 37652349 DOI: 10.1016/j.jaip.2023.08.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/20/2022] [Revised: 08/17/2023] [Accepted: 08/20/2023] [Indexed: 09/02/2023]
Abstract
BACKGROUND Omalizumab (OMA) dramatically improves disease control and quality of life in patients with chronic urticaria (CU). OBJECTIVE We aimed to evaluate the discontinuation patterns of OMA and their determinants in a cohort of French patients with CU. METHODS We conducted a retrospective multicenter study in 9 French tertiary referral hospitals. All patients diagnosed with either spontaneous (CSU) and/or inducible (CIndU) CU who received at least 1 injection of OMA between 2009 and 2021 were included. We analyzed OMA drug survival and investigated possible determinants using Kaplan-Meier curves and log-rank tests. RESULTS A total of 878 patients were included in this study; 48.8% had CSU, 10.1% CIndU, and 41.1% a combination of both. OMA was discontinued in 408 patients, but the drug was later reintroduced in 50% of them. The main reason for discontinuing treatment was the achievement of a well-controlled disease in 50% of patients. Half of the patients were still being treated with OMA 2.4 years after the initiation of treatment. Drug survival was shorter in patients with CIndU and in those with an autoimmune background. In atopic patients, OMA was discontinued earlier in patients achieving a well-controlled disease. A longer OMA drug survival was observed in patients with a longer disease duration at initiation. CONCLUSION In French patients with CU, the drug survival of OMA appears to be longer than that observed in previous studies conducted elsewhere, highlighting discrepancies in prescription and reimbursement possibilities. Further studies are warranted to develop customized OMA treatment schemes based on individual patterns.
Collapse
Affiliation(s)
- Julie Litovsky
- Département de Dermatologie, C.H.U de Montpellier, Montpellier, France
| | - Florence Hacard
- Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Allergologie et Immunologie Clinique, Pierre Bénite, France
| | - Florence Tétart
- Centre Erik Satie-Allergologie, Rouen University Hospital, Rouen, France
| | - Isabelle Boccon-Gibod
- Service de Médecine Interne, Centre National de Référence des Angioedèmes, CHU de Grenoble, Échirolles, France
| | - Angèle Soria
- Service de Dermatologie et Allergologie, Hôpital Tenon AP-HP, Sorbonne Université, Paris, France
| | - Delphine Staumont-Sallé
- CHU Lille, Service de Dermatologie, Université de Lille, INSERM U1286, Lille Inflammation Translational Research Institute (INFINITE) F-59000, Lille, France
| | | | - Emmanuelle Amsler
- Service de Dermatologie et Allergologie, Hôpital Tenon AP-HP, Sorbonne Université, Paris, France
| | - Catherine Mansard
- Service de Médecine Interne, Centre National de Référence des Angioedèmes, CHU de Grenoble, Échirolles, France
| | - Frédéric Dezoteux
- CHU Lille, Service de Dermatologie, Université de Lille, INSERM U1286, Lille Inflammation Translational Research Institute (INFINITE) F-59000, Lille, France
| | | | | | - Claire Bernier
- Plateforme Transversale d'Allergologie, Hôtel-Dieu-CHU de Nantes, Nantes, France
| | - Jean-Luc Perrot
- Service Dermatologie-Allergologie-Oncologie, CHU Nord Saint-Étienne U1059 INSERM, Saint-Priest-en-Jarez, France
| | | | - Marie Paryl
- Laboratoire de Biostatistiques, Épidémiologie, Santé Publique et Innovation Médicale Bespim, CHU De Nîmes, Nîmes, France
| | - Catherine Droitcourt
- Service de Dermatologie, CHU Rennes, Rennes, France; Université Rennes, CHU Rennes, INSERM, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, Rennes, France
| | - Pascal Demoly
- Department of Allergology, University Hospital of Montpellier, Montpellier, France; IDESP UA11 University Montpellier, Montpellier, France
| | - Julien Grosjean
- Département d'Informatique BioMédicale, CHU de Rouen & LIMICS, U1142, Sorbonne Université, Paris, France
| | - Thibault Mura
- Laboratoire de Biostatistiques, Épidémiologie, Santé Publique et Innovation Médicale Bespim, CHU De Nîmes, Nîmes, France
| | - Aurélie Du-Thanh
- Département de Dermatologie, C.H.U de Montpellier, Montpellier, France.
| |
Collapse
|
6
|
Castagna J, Chasset F, Autegarden JE, Le Thai C, Amsler E, Barbaud A, Soria A. Assessing delayed penicillin hypersensitivity using the PENFAST+ score. Front Allergy 2023; 4:1302567. [PMID: 38026134 PMCID: PMC10680989 DOI: 10.3389/falgy.2023.1302567] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Accepted: 10/30/2023] [Indexed: 12/01/2023] Open
Abstract
Introduction Approximately 10% of individuals report a suspected allergy to penicillin, but according to allergy work-ups, only 10%-15% of them are truly allergic. A clinical decision score, the PEN-FAST, was developed and validated to identify adults with low-risk penicillin allergy. Objectives The objective of this study was to improve the performance of the PEN-FAST score, particularly for those with delayed hypersensitivity (HS), by improving the negative predictive value. Methods STEP 1: Retrospective evaluation of the PEN-FAST score in patients with proven immediate and delayed penicillin allergy. STEP 2: Identification of additional criteria among Step 1 patients misclassified by PEN-FAST score. Development of the PEN-FAST+ score using multivariable logistic regression in a prospective cohort of patients with a suspicion of HS to penicillin. STEP 3: Comparison of diagnostic performances of PEN-FAST and PEN-FAST+ scores. Results The PEN-FAST score showed limitations in predicting the relapse of immediate skin HS or delayed maculopapular exanthema, with 28.6% and 38.4% of patients misclassified, respectively. We identified two potential additional criteria: skin rash lasting more than 7 days and immediate reaction occurring in less than 1 h (generalized or localized on palmoplantar area or scalp itching/heat feeling). A total of 32/252 (12.7%) patients were confirmed to be allergic to penicillin. With PEN-FAST, 37% of patients (n = 10) with delayed allergic penicillin HS were misclassified. With PEN-FAST+, 3 patients with delayed HS confirmed by a ST (11.1%) were misclassified. The AUC was significantly higher for PEN-FAST+ than PEN-FAST (85% vs. 72%, p = 0.03).
Collapse
Affiliation(s)
- Julie Castagna
- Médecine Sorbonne Université, Service de dermatologie et d’allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - François Chasset
- Médecine Sorbonne Université, Service de dermatologie et d’allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
- Centre d’Immunologie et de Maladies Infectieuses, Cimi-Paris, INSERM, Paris, France
| | - Jean-Eric Autegarden
- Médecine Sorbonne Université, Service de dermatologie et d’allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Claire Le Thai
- Médecine Sorbonne Université, Service de dermatologie et d’allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Emmanuelle Amsler
- Médecine Sorbonne Université, Service de dermatologie et d’allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Annick Barbaud
- Médecine Sorbonne Université, Service de dermatologie et d’allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
- INSERM, Institut Pierre Louis d’Epidémiologie et de Sante Publique, Paris, France
| | - Angèle Soria
- Médecine Sorbonne Université, Service de dermatologie et d’allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
- Centre d’Immunologie et de Maladies Infectieuses, Cimi-Paris, INSERM, Paris, France
| |
Collapse
|
7
|
Amsler E, Mahevas T, Soria A, Barbaud A. Fixed food eruption to Moringa oleifera. Contact Dermatitis 2023; 89:301-302. [PMID: 37455586 DOI: 10.1111/cod.14383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Revised: 07/03/2023] [Accepted: 07/04/2023] [Indexed: 07/18/2023]
Affiliation(s)
- Emmanuelle Amsler
- Médecine Sorbonne Université, Service de dermatologie et d'allergologie, Hôpital Tenon, Assistance Publique des Hôpitauxde Paris (AP-HP), Hôpital Tenon, AP-HP, Paris, France
| | | | - Angele Soria
- Médecine Sorbonne Université, Service de dermatologie et d'allergologie, Hôpital Tenon, Assistance Publique des Hôpitauxde Paris (AP-HP), Hôpital Tenon, AP-HP, Paris, France
- Cimi-Paris, INSERM 1135, Paris, France
| | - Annick Barbaud
- Médecine Sorbonne Université, Service de dermatologie et d'allergologie, Hôpital Tenon, Assistance Publique des Hôpitauxde Paris (AP-HP), Hôpital Tenon, AP-HP, Paris, France
- INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP Sorbonne Université, Paris, France
| |
Collapse
|
8
|
Barbaud A, Kurihara F, Raison-Peyron N, Milpied B, Valois A, Assier H, Morice C, Manciet JR, Gener G, Giordano-Labadie F, Marcant P, Bernier C, Amsler E, Crepy MN, Tetart F, Soria A, le Bouëdec MCF. Allergic contact dermatitis from essential oil in consumer products: Mode of uses and value of patch-tests with an essential oil series. Results of a French study of the DAG (dermato-allergy group of the French Society of Dermatology). Contact Dermatitis 2023. [PMID: 37403438 DOI: 10.1111/cod.14377] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Revised: 06/21/2023] [Accepted: 06/23/2023] [Indexed: 07/06/2023]
Abstract
OBJECTIVE To analyse the clinical characteristics and sensitivity of an essential oil patch-test series (EOS) in patients sensitized to their own essential oils (EOs). METHOD We analysed the clinical data and patch-test results obtained with the European baseline series (BSE) and an EOS, as well as the mode of use of EOs, through a questionnaire included in the patient file. RESULTS The study included 42 patients (79% women, average age 50 years) with allergic contact dermatitis (ACD), 8 patients required hospitalization. All patients were sensitized to the EO they used, primarily lavender (Lavandula augustifolia, 8000-28-0), tea tree (Melaleuca alternifolia leaf oil, 68647-73-4), ravintsara (Cinnamomum camphora oil, 92201-50-8), and 2 cases were attributed to helichrysum (helichrysum italicum flower absolute, 90045-56-0). 71% had positive patch tests to fragrance mix I or II, 9 only to the EOS and 4 only with their personal EO. Interestingly, 40% of patients did not spontaneously mention the use of EOs, and only 33% received advice on their use at the time of purchase. CONCLUSION Patch-tests with the BSE, limonene and linalool HP, and oxidized tea tree oil is sufficient to detect most EO-sensitized patients. The most important is to test the patient's own used EOs.
Collapse
Affiliation(s)
- Annick Barbaud
- Dermatology and Allergy Department, Médecine Sorbonne Université, Service de dermatologie et d'allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Tenon Hospital, AP-HP, Paris, France
- Department of Dermatology and Allergology, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, AP-HP Sorbonne Universite, Tenon Hopital, Paris, France
| | - Flore Kurihara
- Dermatology and Allergy Department, Médecine Sorbonne Université, Service de dermatologie et d'allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Tenon Hospital, AP-HP, Paris, France
| | | | | | - Aude Valois
- Department of Dermatology, HIA, Toulon, France
| | - Haudrey Assier
- Department of Dermatology, CHU Henri-Mondor, Créteil, France
| | | | | | | | | | | | - Claire Bernier
- Department of Dermatology, Nantes University Hospital, Nantes, France
| | - Emmanuelle Amsler
- Dermatology and Allergy Department, Médecine Sorbonne Université, Service de dermatologie et d'allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Tenon Hospital, AP-HP, Paris, France
| | - Marie Noelle Crepy
- Department of Occupational and Environmental Diseases, Hotel-Dieu Hospital, Paris, France
| | | | - Angèle Soria
- Dermatology and Allergy Department, Médecine Sorbonne Université, Service de dermatologie et d'allergologie, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Tenon Hospital, AP-HP, Paris, France
| | | |
Collapse
|
9
|
Brehon A, Soria A, Barbaud A, Amsler E. Allergic contact dermatitis caused by PEG-22 and PEG-45 dodecyl glycol copolymers in two skin-repairing creams. Contact Dermatitis 2023. [PMID: 37365836 DOI: 10.1111/cod.14369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Revised: 05/26/2023] [Accepted: 06/06/2023] [Indexed: 06/28/2023]
Affiliation(s)
- Alice Brehon
- Dermatology and Allergy Department, Médecine Sorbonne Université, Tenon Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Angèle Soria
- Dermatology and Allergy Department, Médecine Sorbonne Université, Tenon Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
- Cimi-Paris, INSERM 1135, Paris, France
| | - Annick Barbaud
- Dermatology and Allergy Department, Médecine Sorbonne Université, Tenon Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
- INSERM, Institut Pierre Louis d'Epidémiologie et de Sante Publique, AP-HP, Sorbonne Université, Paris, France
| | - Emmanuelle Amsler
- Dermatology and Allergy Department, Médecine Sorbonne Université, Tenon Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| |
Collapse
|
10
|
Clément A, Ferrier le Bouëdec MC, Crépy MN, Raison-Peyron N, Tétart F, Marcant P, Pralong P, Valois A, Pasteur J, Assier H, Bernier C, Le Cam MT, Hacard F, Nosbaum A, Giordano Labadie F, Morice C, Leleu C, Milpied B, Darrigade AS, Delaunay J, Barbaud A, Castelain F, Collet E, Amsler E. Hand eczema in glove-wearing patients. Contact Dermatitis 2023. [PMID: 37331721 DOI: 10.1111/cod.14357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2023] [Revised: 04/28/2023] [Accepted: 05/25/2023] [Indexed: 06/20/2023]
Abstract
BACKGROUND Allergic contact dermatitis to gloves is mostly induced by rubber accelerators. The European baseline series (EBS) appears insufficient to detect glove allergy. Since 2017, it is recommended to use the European rubber series (ERS) and to test the patients' own gloves. OBJECTIVES To investigate the clinical profile of glove-wearing patients with hand eczema (HE) and to evaluate their sensitisation profile to glove allergens and the value of testing the patients' own gloves. METHODS We conducted a French multicentre study of patients evaluated for HE between 2018 and 2020 and tested with the EBS, the ERS and their own gloves in patch tests and semi-open (SO) tests. RESULTS A total of 279 patients were included; 32.6% of patients had positive tests to their own gloves or to glove allergens. Almost 45% of the sensitisations to glove allergens were detected only by the ERS. Among the patients tested both in patch tests and SO tests with their own gloves with positive results, 28% had positive SO tests only. Polyvinylchloride (PVC) gloves were positive in four patients. CONCLUSION Our series confirms the need to test the ERS. All the patients' gloves must also be tested including PVC gloves. SO tests with gloves are useful as a complement to patch tests.
Collapse
Affiliation(s)
- Aude Clément
- Department of Dermatology, Hôpital Estaing, CHU Clermont-Ferrand, Clermont-Ferrand, France
| | | | - Marie-Noëlle Crépy
- Department of Dermatology, Hôpital Cochin Port-Royal, APHP, Paris, France
| | - Nadia Raison-Peyron
- Department of Dermatology, Hôpital Saint Eloi, CHU Montpellier, Montpellier, France
| | - Florence Tétart
- Department of Allergology, Centre Erik Satie, CHU Rouen, Rouen, France
| | - Pierre Marcant
- Department of Dermatology, Hôpital Claude Huriez, CHU Lille, Lille, France
| | - Pauline Pralong
- Department of Dermatology, Hôpital Nord, CHU Grenoble, La Tronche, France
| | - Aude Valois
- Department of Dermatology, Hôpital d'instruction des armées Sainte Anne, Toulon, France
| | - Justine Pasteur
- Department of Dermatology, Hôpital Estaing, CHU Clermont-Ferrand, Clermont-Ferrand, France
| | - Haudrey Assier
- Department of Dermatology, CHU Henri Mondor, Créteil, France
| | - Claire Bernier
- Department of Dermatology, Hôpital Hotel Dieu, CHU Nantes, Nantes, France
| | - Marie-Thérèse Le Cam
- Department of Professional Pathology, Centre hospitalier intercommunal, Créteil, France
| | - Florence Hacard
- Department of Allergology and Immunology, CHU Lyon sud, Lyon, France
| | - Audrey Nosbaum
- Department of Allergology and Immunology, CHU Lyon sud, Lyon, France
| | | | | | - Camille Leleu
- Department of Dermatology, CHU Dijon-Bourgogne, Dijon, France
| | - Brigitte Milpied
- Department of Dermatology, Hôpital Saint-André, CHU Bordeaux, Bordeaux, France
| | | | | | - Annick Barbaud
- Département de dermatologie et allergologie, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP.Sorbonne Université, Hôpital Tenon, Paris, France
| | - Florence Castelain
- Department of Dermatology, Hôpital Jean Minjoz, CHU Besançon, Besançon, France
| | - Evelyne Collet
- Department of Dermatology, CHU Dijon-Bourgogne, Dijon, France
| | - Emmanuelle Amsler
- Département de dermatologie et allergologie, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP.Sorbonne Université, Hôpital Tenon, Paris, France
| |
Collapse
|
11
|
Soria A, Amsler E, Garel B, Moguelet P, Tieulié N, Cordoliani F, Guichard I, Mahé A, Grateau G, Boursier G, Georgin-Lavialle S. Systemic inflammatory trunk recurrent acute macular eruption (SITRAME): A new auto-inflammatory syndrome in adult? J Eur Acad Dermatol Venereol 2023; 37:e538-e542. [PMID: 36426626 DOI: 10.1111/jdv.18771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Accepted: 11/21/2022] [Indexed: 11/27/2022]
Affiliation(s)
- Angèle Soria
- Sorbonne Université, Service de Dermatologie et d'Allergologie, Hôpital Tenon, DMU3ID, APHP, Paris, France.,Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), INSERM U1135, Paris, France
| | - Emmanuelle Amsler
- Sorbonne Université, Service de Dermatologie et d'Allergologie, Hôpital Tenon, DMU3ID, APHP, Paris, France
| | - Bethsabée Garel
- Sorbonne Université, Service de Dermatologie et d'Allergologie, Hôpital Tenon, DMU3ID, APHP, Paris, France
| | | | - Nathalie Tieulié
- Service de Rhumatologie, CHU Nice, Hôpital Pasteur, Nice, France
| | | | | | - Antoine Mahé
- Service de Dermatologie, Hôpital de Colmar, Colmar, France
| | - Gilles Grateau
- Sorbonne Université, Service de médecine interne, Hôpital Tenon, DMU 3ID, APHP, Paris, France.,Centre National de Référence des Maladies Auto-Inflammatoires et des Amyloses D'Origine Inflammatoire (CEREMAIA), Paris, France
| | - Guilaine Boursier
- Centre National de Référence des Maladies Auto-Inflammatoires et des Amyloses D'Origine Inflammatoire (CEREMAIA), Montpellier, France.,Laboratoire de Génétique des Maladies rares et autoinflammatoires, Service de Génétique moléculaire et cytogénomique, CHU Montpellier, Univ Montpellier, Montpellier, France
| | - Sophie Georgin-Lavialle
- Sorbonne Université, Service de médecine interne, Hôpital Tenon, DMU 3ID, APHP, Paris, France.,Centre National de Référence des Maladies Auto-Inflammatoires et des Amyloses D'Origine Inflammatoire (CEREMAIA), Paris, France.,INSERM U938, CRSA, Paris, France
| |
Collapse
|
12
|
Colboc H, Bazin D, Reguer S, Lucas IT, Moguelet P, Amode R, Jouanneau C, Soria A, Chasset F, Amsler E, Pecquet C, Aractingi S, Bellot-Gurlet L, Deschamps L, Descamps V, Kluger N. Chemical characterization of inks in skin reactions to tattoo. J Synchrotron Radiat 2022; 29:1436-1445. [PMID: 36345752 PMCID: PMC9641572 DOI: 10.1107/s1600577522008165] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/07/2022] [Accepted: 08/15/2022] [Indexed: 06/16/2023]
Abstract
Skin reactions are well described complications of tattooing, usually provoked by red inks. Chemical characterizations of these inks are usually based on limited subjects and techniques. This study aimed to determine the organic and inorganic composition of inks using X-ray fluorescence spectroscopy (XRF), X-ray absorption spectroscopy (XANES) and Raman spectroscopy, in a cohort of patients with cutaneous hypersensitivity reactions to tattoo. A retrospective multicenter study was performed, including 15 patients diagnosed with skin reactions to tattoos. Almost half of these patients developed skin reactions on black inks. XRF identified known allergenic metals - titanium, chromium, manganese, nickel and copper - in almost all cases. XANES spectroscopy distinguished zinc and iron present in ink from these elements in endogenous biomolecules. Raman spectroscopy showed the presence of both reported (azo pigments, quinacridone) and unreported (carbon black, phtalocyanine) putative organic sensitizer compounds, and also defined the phase in which Ti was engaged. To the best of the authors' knowledge, this paper reports the largest cohort of skin hypersensitivity reactions analyzed by multiple complementary techniques. With almost half the patients presenting skin reaction on black tattoo, the study suggests that black modern inks should also be considered to provoke skin reactions, probably because of the common association of carbon black with potential allergenic metals within these inks. Analysis of more skin reactions to tattoos is needed to identify the relevant chemical compounds and help render tattoo ink composition safer.
Collapse
Affiliation(s)
- Hester Colboc
- Sorbonne Université, Hôpital Rothschild, Service de Gériatrie-Plaies et Cicatrisation, Paris, France
- Sorbonne Université, UPMC Paris 06, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S 1155, F-75020 Paris, France
| | - Dominique Bazin
- Institut de Chimie Physique, Université Paris-Saclay, Orsay, France
| | - Solenn Reguer
- DiffAbs Beamline, Synchrotron SOLEIL, L’Orme des Merisiers, Départementale 128, 91190 Saint-Aubin, France
| | - Ivan T. Lucas
- Sorbonne Université, CNRS, Laboratoire Lise UMR 8235, Paris, France
| | - Philippe Moguelet
- Sorbonne Université, Hôpital Tenon, Anatomie et Cytologie Pathologiques, Paris, France
| | | | - Chantal Jouanneau
- Sorbonne Université, UPMC Paris 06, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S 1155, F-75020 Paris, France
| | - Angèle Soria
- Sorbonne Université, Hôpital Tenon, Service de Dermatologie-Allergologie, Paris, France
| | - François Chasset
- Sorbonne Université, Hôpital Tenon, Service de Dermatologie-Allergologie, Paris, France
| | - Emmanuelle Amsler
- Sorbonne Université, Hôpital Tenon, Service de Dermatologie-Allergologie, Paris, France
| | - Catherine Pecquet
- Sorbonne Université, Hôpital Tenon, Service de Dermatologie-Allergologie, Paris, France
| | - Sélim Aractingi
- Université de Paris, Hôpital Cochin, Service de Dermatologie, Paris, France
| | | | - Lydia Deschamps
- Université de Paris, Hôpital Bichat, Service d’Anatomie et Cytologie Pathologique, Paris, France
| | - Vincent Descamps
- Université de Paris, Hôpital Bichat, Service de Dermatologie, Paris, France
| | - Nicolas Kluger
- Université de Paris, Hôpital Bichat, Service de Dermatologie, Paris, France
- Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| |
Collapse
|
13
|
Du-Thanh A, Soria A, Amsler E, Badaoui A, Doutre MS, Gabison G, Bernier C, Staumont-Sallé D, Hacard F, Castelain F, Darrigade AS, Tapsoba GPML, Sarre ME, Mathelier-Fusade P, Delaunay J, Pralong P, Barbaud A, Dezoteux F, Trémeau-Martinage C, Bachtarzi Z, Augey F. Discrepancies in the management of acquired cold contact urticaria: Results of a French-speaking urticaria experts questionnaire survey. World Allergy Organ J 2022; 15:100688. [PMID: 36092949 PMCID: PMC9421398 DOI: 10.1016/j.waojou.2022.100688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2021] [Revised: 08/02/2022] [Accepted: 08/02/2022] [Indexed: 11/27/2022] Open
Abstract
Acquired cold contact urticaria (ACU) is a putatively serious condition, because of the risk of anaphylactic shock whenever patients are massively exposed to cold atmosphere/water, raising the question of the prescription of an “emergency kit” with oral antihistamines and epinephrine auto-injector. We performed an online survey to evaluate how French-speaking urticaria experts manage ACU. According to the 2016 consensus recommendations on chronic inducible urticarias, all the participants perform at least 1 of the available provocation tests and 84.2%, 77.8%, and 88.9% prescribe on-label use of second generation anti-H1 antihistamines (2GAH1) as a first line treatment, updosed 2GAH1 as a second line treatment, and omalizumab as a third line treatment, respectively. Interestingly, 44.4% of the practitioners always prescribe a continuous background treatment, versus 11.1% prescribing only on-demand therapy. Also, 11.7% of participants always prescribe an epinephrine auto-injector, 70.6% sometimes do, and 17.6% never do. Finally, 89.5% authorize swimming under strict conditions but 36.8% and 68.4% contra-indicate other water sports and occupational cold exposure, respectively.
Collapse
|
14
|
Amsler E, Assier H, Soria A, Bara C, Ferrier le Bouëdec MC, Barbaud A, Milpied B, Giordano-Labadie F, Pasteur J, Badaoui A, Valois A, Castelain F, Kurihara F, Castagna J, Boulard C, Bernier C, Leleu C, Marcant P, Crépy MN, Tetart F, Raison-Peyron N. What is the optimal duration for a ROAT? The experience of the French Dermatology and Allergology Group (DAG). Contact Dermatitis 2022; 87:170-175. [PMID: 35383393 DOI: 10.1111/cod.14118] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2021] [Revised: 03/22/2022] [Accepted: 03/25/2022] [Indexed: 11/28/2022]
Abstract
The repeated open application test (ROAT) is an adjuvant investigation measure to patch testing in the diagnosis of allergic contact dermatitis. ESCD recommends a 15 days duration but its overall duration varies according to publications and patients hardly adhere to prolonged ROAT duration beyond one week . MATERIEL AND METHOD The Dermatology and Allergy Group of the French Society of Dermatology performed a prospective study with the aim of determining the best duration for the ROAT. RESULTS A total of 328 ROAT results were collected for topical products, including cosmetics (60%) and topical medications (31.1%). Fifty-nine (18%) ROATs were positive, and 16 (5%) were doubtful. All the positive ROATs occurred within 10 days, with a median time to positivity of 3 days. CONCLUSION According to our results, a minimum duration of 10 days is necessary to achieve a positive ROAT to a topical product. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Emmanuelle Amsler
- Service de dermatologie et allergologie, Hôpital Tenon, 4 rue de la Chine 75020 PARIS
| | - Haudrey Assier
- Service de Dermatologie, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, 94010 Créteil
| | - Angèle Soria
- Service de dermatologie et allergologie, Hôpital Tenon, 4 rue de la Chine 75020 PARIS
| | - Corina Bara
- Service de Dermatologie, 194, avenue rubillard, 72000 Le Mans
| | | | - Annick Barbaud
- Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP. Sorbonne Université, Hôpital Tenon, Département de dermatologie et allergologie, Paris
| | - Brigitte Milpied
- Service de Dermatologie, Hôpital St André, 1 rue Jean Burguet,33075 Bordeaux
| | | | - Justine Pasteur
- Service de dermatologie, CHU Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand
| | - Antoine Badaoui
- Service de dermatologie, Hôpital d'Instruction des Armées Bégin, 69 avenue de Paris, 94160 St Mandé
| | - Aude Valois
- Service de dermatologie, Hôpital d'Instruction des Armées Sainte Anne 2 boulevard Sainte Anne, 83800 Toulon Cedex 03
| | | | - Flore Kurihara
- Service de dermatologie et allergologie, Hôpital Tenon, 4 rue de la Chine 75020 PARIS
| | - Julie Castagna
- Service de dermatologie et allergologie, Hôpital Tenon, 4 rue de la Chine 75020 PARIS
| | | | - Claire Bernier
- service de dermatologie, CHU Hôtel Dieu, 1 place Alexis Ricordeau 44093 Nantes Cedex 1
| | - Camille Leleu
- Service de Dermatologie, CHU François Mitterrand, 14 rue Paul Gaffarel 21 000 DIJON
| | - Pierre Marcant
- Centre hospitalier universitaire de Lille, Service de dermatologie, Lille, France
| | - Marie Noelle Crépy
- Department of Occupational and Environmental Diseases, University Hospital of Centre of Paris, Hotel-Dieu Hospital, AP-HP, Paris, France.,Department of Dermatology, University Hospital of Centre of Paris, Cochin Hospital, AP-HP, Paris, France
| | - Florence Tetart
- Centre Erik Satie Allergologie, Rouen University Hospital, 1 rue de Germont 76031 Rouen cedex
| | | | | |
Collapse
|
15
|
Amsler E, Soria A, Barbaud A. Two cases of allergic contact dermatitis to Tamanu oil. Contact Dermatitis 2022; 87:99-100. [PMID: 35293632 DOI: 10.1111/cod.14106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2022] [Revised: 03/06/2022] [Accepted: 03/11/2022] [Indexed: 11/30/2022]
Affiliation(s)
- Emmanuelle Amsler
- Service de Dermatologie et Allergologie, Medecine Sorbonne Université, Hôpital Tenon, AP-HP.Sorbonne Université, 4 rue de la Chine, Paris, France
| | - Angele Soria
- Service de Dermatologie et Allergologie, Medecine Sorbonne Université, Hôpital Tenon, AP-HP.Sorbonne Université, 4 rue de la Chine, Paris, France
| | - Annick Barbaud
- Service de Dermatologie et Allergologie, Medecine Sorbonne Université, Hôpital Tenon, AP-HP.Sorbonne Université, 4 rue de la Chine, Paris, France
| |
Collapse
|
16
|
Brehon A, Moguelet P, Seta V, Amsler E, Fajac A, Barbaud A, Soria A, Monfort JB. Clinical and histological characteristics during chronic urticaria with dermal neutrophilic infiltrate: Proposal of a diagnostic score. J Eur Acad Dermatol Venereol 2021; 36:e304-e306. [PMID: 34742165 DOI: 10.1111/jdv.17788] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Revised: 09/22/2021] [Accepted: 10/22/2021] [Indexed: 11/29/2022]
Affiliation(s)
- A Brehon
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - P Moguelet
- AP-HP, Service de Pathologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - V Seta
- AP-HP, Service de Dermatologie, Hôpital Cochin, Université de Paris, Paris, 75014, France.,Service de Chirurgie Maxillo-Faciale, Chirurgie Orale et Stomatologie, CHU d'Angers, Angers, France
| | - E Amsler
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - A Fajac
- AP-HP, Service de Pathologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - A Barbaud
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - A Soria
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - J B Monfort
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| |
Collapse
|
17
|
Le Seac'h A, Castagna J, Chantran Y, Kurihara F, Amsler E, Soria A, Barbaud A. Occurrence of immediate and delayed hypersensitivity to hexamidine. Contact Dermatitis 2021; 85:580-582. [PMID: 34021916 DOI: 10.1111/cod.13906] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2021] [Revised: 05/10/2021] [Accepted: 05/18/2021] [Indexed: 12/27/2022]
Affiliation(s)
| | - Julie Castagna
- Department of dermatology, Tenon Hospital, Paris, France
| | - Yannick Chantran
- Immunology Department, Biological Allergology Unit, Hôpital Trousseau, Sorbonne Université, Paris, France
| | - Flore Kurihara
- Department of dermatology, Tenon Hospital, Paris, France
| | | | - Angèle Soria
- Department of dermatology, Tenon Hospital, Paris, France.,Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), INSERM U1135, Paris, France
| | - Annick Barbaud
- Department of dermatology, Tenon Hospital, Paris, France
| |
Collapse
|
18
|
Soria A, Amsler E, Bernier C, Milpied B, Tétart F, Morice C, Dezoteux F, Ferrier-Le Bouedec MC, Barbaud A, Staumont-Sallé D, Assier H. DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case Series. J Allergy Clin Immunol Pract 2021; 9:3041-3050. [PMID: 33757916 DOI: 10.1016/j.jaip.2021.02.060] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/04/2021] [Revised: 02/23/2021] [Accepted: 02/28/2021] [Indexed: 12/17/2022]
Abstract
BACKGROUND Drug reactions with eosinophilia and systemic symptoms (DRESSs) and acute generalized exanthematous pustulosis (AGEP) are potentially severe cutaneous adverse drug reactions. OBJECTIVE To describe the clinical findings and sensitization profiles of DRESS and AGEP patients who had been administered iodinated contrast media (ICM). METHODS All adult patients in the dermatologist's French Investigators for Skin Adverse Reactions to Drugs (FISARD) network diagnosed with a DRESS or AGEP highly suspected to have been caused by an ICM were included retrospectively. RESULTS Thirteen DRESS patients and 19 AGEP patients who had been administered ICM were included, and the median delay in DRESS and AGEP occurrence after ICM administration was short, 4 and 1 days, respectively. Five AGEP patients had systemic involvement. A high cosensitization rate (46%) was observed among the DRESS patients, mainly with beta-lactam antibiotics. Overall, 77% of our patients were sensitized to several ICM. Patch tests identified the suspected ICM for 21 cases (72%). The retrospective nature, the limited number of subjects, the absence of a control group of healthy individuals, and the lack of detailed information on previous exposure to sensitizing drugs are limitations of this study. CONCLUSIONS We report a large series of DRESSs and AGEPs related to ICM administration. Skin tests appear useful for diagnosis and potentially to identify alternative ICM.
Collapse
Affiliation(s)
- Angèle Soria
- Sorbonne Universités, Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Centre d'Immunologie et des Maladies Infectieuses, INSERM U1135, Paris, France.
| | - Emmanuelle Amsler
- Sorbonne Universités, Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France
| | - Claire Bernier
- Service de Dermatologie, Hôpital Hôtel Dieu, CHU Nantes, France
| | | | - Florence Tétart
- Clinique dermatologique CHU de Rouen et Centre Erik Satie, Allergologie CHU Rouen, France
| | | | | | | | - Annick Barbaud
- Sorbonne Universités, Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France
| | | | - Haudrey Assier
- Service de Dermatologie, Hôpital Henri Mondor, APHP, Créteil, France
| |
Collapse
|
19
|
Kurihara F, Milpied B, Ferrier Le Bouëdec M, Raison Peyron N, Morice C, Manciet J, Assier H, Gener G, Giordano Labadie F, Marcant P, Pralong P, Tétard F, Bernier C, Badaoui A, Chasset F, Soria A, Amsler E, Barbaud A. Caractéristiques d’utilisation des huiles essentielles des patients avec un eczéma de contact prouvé aux huiles essentielles et évaluation d’une batterie huile essentielle : étude descriptive du DAG. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
20
|
Hamelin A, Amsler E, Barbaud A, Soria A. Deux cas de prurit cholinergique. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
21
|
Mascitti H, Gaouar H, Amsler E, Autegarden JE, Bayrou O, De Risi-Pugliese T, Haddad T, Hamelin A, Mathelier-Fusade P, Pecquet C, Thetis M, Kurihara F, Soria A, Barbaud A. Tolerance of Iodixanol, a nonionic, isosmolar contrast agent in case of immediate hypersensitivity reactions to radiocontrast media. World Allergy Organ J 2020. [DOI: 10.1016/j.waojou.2020.100391] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
22
|
Chiron A, Gaouar H, Autegarden JE, Amsler E, Barbaud A, Soria A. Cross-reactivity with third and second generation cephalosporins in truly penicillin allergic patients. World Allergy Organ J 2020. [DOI: 10.1016/j.waojou.2020.100245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
23
|
Castagna J, Amsler E, Kurihara F, Chasset F, Barbaud A, Soria A. Atypical features of cutaneous adverse drug reactions during therapy for hairy cell leukemia. J Allergy Clin Immunol Pract 2020; 8:3203-3206.e1. [PMID: 32553830 DOI: 10.1016/j.jaip.2020.06.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/31/2020] [Revised: 05/31/2020] [Accepted: 06/01/2020] [Indexed: 12/11/2022]
Affiliation(s)
- Julie Castagna
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, Sorbonne Universités, Paris, France.
| | - Emmanuelle Amsler
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, Sorbonne Universités, Paris, France
| | - Flore Kurihara
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, Sorbonne Universités, Paris, France
| | - François Chasset
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, Sorbonne Universités, Paris, France
| | - Annick Barbaud
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, Sorbonne Universités, Paris, France
| | - Angèle Soria
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, Sorbonne Universités, Paris, France; Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), INSERM U1135, Paris, France
| |
Collapse
|
24
|
de Risi-Pugliese T, Barailler H, Hamelin A, Amsler E, Gaouar H, Kurihara F, Jullie ML, Merrill ED, Barbaud A, Moguelet P, Milpied-Homsi B, Soria A. Symmetrical drug-related intertriginous and flexural exanthema: A little-known drug allergy. J Allergy Clin Immunol Pract 2020; 8:3185-3189.e4. [PMID: 32376489 DOI: 10.1016/j.jaip.2020.04.052] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/23/2019] [Revised: 04/08/2020] [Accepted: 04/21/2020] [Indexed: 12/20/2022]
Affiliation(s)
- Tullia de Risi-Pugliese
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France; Sorbonne Université, UPMC University, Paris, France.
| | | | - Aurore Hamelin
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Emmanuelle Amsler
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France; Sorbonne Université, UPMC University, Paris, France
| | - Hafida Gaouar
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Flore Kurihara
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France; Sorbonne Université, UPMC University, Paris, France
| | | | - Eric Dean Merrill
- Department of Dermatology, University of California San Francisco, San Francisco, Calif
| | - Annick Barbaud
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France; Sorbonne Université, UPMC University, Paris, France
| | | | | | - Angèle Soria
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France; Sorbonne Université, UPMC University, Paris, France; Inserm 1135, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France
| |
Collapse
|
25
|
Amsler E, Du Thanh A, Soria A. Management of urticaria by French specialists compared to international guideline recommendations. J Allergy Clin Immunol Pract 2020; 8:1761-1763.e2. [PMID: 31945488 DOI: 10.1016/j.jaip.2019.12.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/13/2019] [Revised: 12/19/2019] [Accepted: 12/31/2019] [Indexed: 06/10/2023]
Affiliation(s)
- Emmanuelle Amsler
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Sorbonne Universités, Paris, France.
| | - Aurelie Du Thanh
- Service de Dermatologie, Hôpital Saint-Eloi, CHU de Montpellier, Montpellier, France
| | - Angèle Soria
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Sorbonne Universités, Paris, France
| |
Collapse
|
26
|
Chiron A, Gaouar H, Autegarden JE, Amsler E, Barbaud A, Soria A. Allergy to third- and second-generation cephalosporins in confirmed penicillin-allergic patients. J Allergy Clin Immunol Pract 2020; 8:2409-2411.e3. [PMID: 32268214 DOI: 10.1016/j.jaip.2020.03.021] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2019] [Revised: 02/21/2020] [Accepted: 03/10/2020] [Indexed: 11/15/2022]
Affiliation(s)
- Andrada Chiron
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France; Sorbonne Universités, Paris, France.
| | - Hafida Gaouar
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France; Sorbonne Universités, Paris, France
| | - Jean-Eric Autegarden
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France; Sorbonne Universités, Paris, France
| | - Emmanuelle Amsler
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France; Sorbonne Universités, Paris, France
| | - Annick Barbaud
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France; Sorbonne Universités, Paris, France
| | - Angèle Soria
- Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France; Sorbonne Universités, Paris, France; Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), INSERM U1135, Paris, France
| |
Collapse
|
27
|
Doutre MS, Taieb C, Richard MA, Soria A, Amsler E, Hacard F, Augey F, Mathelier-Fusade P. Caractéristiques épidémiologiques de l’urticaire en France. Données de l’étude Objectifs peau. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
28
|
Castagna J, Amsler E, Gaouar H, Hamelin A, De Risi-Pugliese T, Kurihara F, Chasset F, Barbaud A, Soria A. Toxidermies et leucémie à tricholeucocytes : une association non fortuite. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
29
|
Leducq S, Samimi M, Bernier C, Soria A, Amsler E, Staumont-Sallé D, Gabison G, Chosidow O, Bénéton N, Bara C, Grange-Prunier A, Wierzbicka-Hainaut E, Brenaut E, Droitcourt C, Rayson-Peyron N, Bourgoin H, Cornillier H, Machet L, Giraudeau B, Caille A, Maruani A. Efficacité du méthotrexate en adjonction d’un traitement par anti-histaminiques H1 dans le traitement de l’urticaire chronique spontanée sévère réfractaire aux anti-H1 seuls : essai de phase III, randomisé, en double aveugle (NCT01960283). Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
30
|
Amsler E, Soria A, Doutre MS. Importance of patients' photographs for urticaria diagnosis. J Allergy Clin Immunol Pract 2019; 7:2927-2928. [PMID: 31150788 DOI: 10.1016/j.jaip.2019.05.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2019] [Revised: 04/03/2019] [Accepted: 05/08/2019] [Indexed: 06/09/2023]
Affiliation(s)
- Emmanuelle Amsler
- Service de Dermatologie et Allergologie, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France; Sorbonne Université, UPMC Univ Paris 06, Paris, France
| | - Angèle Soria
- Service de Dermatologie et Allergologie, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France; Sorbonne Université, UPMC Univ Paris 06, Paris, France; Cimi-Paris, INSERM U1135, Paris, France
| | - Marie-Sylvie Doutre
- Service de Dermatologie, Hôpital Saint-André, CHU de Bordeaux, Bordeaux, France.
| |
Collapse
|
31
|
Soria A, Hamelin A, Risi Pugliese T, Amsler E, Barbaud A. Are drug intradermal tests dangerous to explore cross‐reactivity and co‐sensitization in DRESS? Br J Dermatol 2019; 181:611-612. [DOI: 10.1111/bjd.17835] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- A. Soria
- Service de Dermatologie et d'Allergologie Hôpital Tenon Paris HUEP, APHP, Paris, France Sorbonne Universités Paris
- Centre d'Immunologie et des Maladies Infectieuses – Paris (Cimi‐Paris), INSERM U1135 Paris France
| | - A. Hamelin
- Service de Dermatologie et d'Allergologie Hôpital Tenon Paris HUEP, APHP, Paris, France Sorbonne Universités Paris
| | - T. Risi Pugliese
- Service de Dermatologie et d'Allergologie Hôpital Tenon Paris HUEP, APHP, Paris, France Sorbonne Universités Paris
| | - E. Amsler
- Service de Dermatologie et d'Allergologie Hôpital Tenon Paris HUEP, APHP, Paris, France Sorbonne Universités Paris
| | - A. Barbaud
- Service de Dermatologie et d'Allergologie Hôpital Tenon Paris HUEP, APHP, Paris, France Sorbonne Universités Paris
| |
Collapse
|
32
|
Monfort JB, Moguelet P, Amsler E, Francès C, Barbaud A, Soria A. [What is neutrophilic urticaria?]. Ann Dermatol Venereol 2019; 146:346-353. [PMID: 30910338 DOI: 10.1016/j.annder.2019.01.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2018] [Revised: 10/24/2018] [Accepted: 01/30/2019] [Indexed: 11/17/2022]
Abstract
Some debate continues to surround the existence of neutrophilic urticaria (NU) as a nosological entity. Certain authors consider NU as a banal form of urticaria since an infiltrate predominantly made up of polynuclear neutrophils (PNN) is seen in certain cases of chronic and acute urticaria. Moreover, it has been stated that the histological appearance of chronic urticaria varies according to the time between appearance of the plaque and the performance of biopsy: the presence of PNN may occur later. According to the literature, there appear to be no specific clinical characteristics associated with the presence of PNN at histology. Most cases exhibit moderate laboratory inflammatory syndrome. Data concerning therapeutic response are contradictory: some studies have shown no significant difference in terms of therapeutic response in relation to banal urticaria, while only one study has demonstrated superior response to dapsone in the case of histologically demonstrated neutrophilic infiltrate. There does not appear to be any disease more frequently associated in the event of NU. In conclusion, the available data concerning NU are insufficient to confirm the existence of this condition. A prospective study comparing routine acute and chronic urticaria biopsies would be extremely useful to better characterise the relationships between cellular infiltrate and therapeutic response.
Collapse
Affiliation(s)
- J-B Monfort
- Service de dermatologie et d'allergologie, HUEP, Sorbonne Universités, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France.
| | - P Moguelet
- Service d'anatomo-pathologie, hôpital Tenon, 4 rue de la Chine, 75020 Paris, France
| | - E Amsler
- Service de dermatologie et d'allergologie, HUEP, Sorbonne Universités, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
| | - C Francès
- Service de dermatologie et d'allergologie, HUEP, Sorbonne Universités, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
| | - A Barbaud
- Service de dermatologie et d'allergologie, HUEP, Sorbonne Universités, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
| | - A Soria
- Service de dermatologie et d'allergologie, HUEP, Sorbonne Universités, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France; Inserm U1135, centre d'immunologie et des maladies infectieuses - Paris (Cimi-Paris), 75013 Paris, France
| |
Collapse
|
33
|
Soria A, Masson N, Vial-Dupuy A, Gaouar H, Amsler E, Chollet-Martin S, Nicaise-Roland P, Autegarden JE, Barbaud A. Allergological workup with half-dose challenge in iodinated contrast media hypersensitivity. Allergy 2019; 74:414-417. [PMID: 30353926 DOI: 10.1111/all.13638] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Affiliation(s)
- Angèle Soria
- Service de Dermatologie et d'Allergologie; Hôpital Tenon; Paris HUEP; APHP; Paris France
- Sorbonne Universités; Paris France
- Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris); INSERM U1135; Paris France
| | - Nathalie Masson
- Service de Dermatologie et d'Allergologie; Hôpital Tenon; Paris HUEP; APHP; Paris France
- Sorbonne Universités; Paris France
| | - Amandine Vial-Dupuy
- Service de Pneumologie et d'Allergologie; Hôpital Saint Joseph; Paris France
| | - Hafida Gaouar
- Service de Dermatologie et d'Allergologie; Hôpital Tenon; Paris HUEP; APHP; Paris France
- Sorbonne Universités; Paris France
| | - Emmanuelle Amsler
- Service de Dermatologie et d'Allergologie; Hôpital Tenon; Paris HUEP; APHP; Paris France
- Sorbonne Universités; Paris France
| | - Sylvie Chollet-Martin
- Hôpitaux Universitaires Paris Nord Val de Seine; Hôpital Bichat; Unité d'Immunologie; Auto-immunité et Hypersensibilités; Paris France
- INSERM; UMR 996; UFR de Pharmacie; Université Paris-Sud; Châtenay-Malabry France
| | - Pascale Nicaise-Roland
- Hôpitaux Universitaires Paris Nord Val de Seine; Hôpital Bichat; Unité d'Immunologie; Auto-immunité et Hypersensibilités; Paris France
| | - Jean-Eric Autegarden
- Service de Dermatologie et d'Allergologie; Hôpital Tenon; Paris HUEP; APHP; Paris France
- Sorbonne Universités; Paris France
| | - Annick Barbaud
- Service de Dermatologie et d'Allergologie; Hôpital Tenon; Paris HUEP; APHP; Paris France
- Sorbonne Universités; Paris France
| |
Collapse
|
34
|
Hamelin A, Amsler E, Mathelier-Fusade P, Pecquet C, Bayrou O, Barbaud A, Soria A. [Omalizumab for the treatment of chronic urticaria: Real-life findings]. Ann Dermatol Venereol 2019; 146:9-18. [PMID: 30638684 DOI: 10.1016/j.annder.2018.07.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Revised: 02/17/2018] [Accepted: 07/30/2018] [Indexed: 10/27/2022]
Abstract
OBJECTIVE Assessment of the efficacy and safety of omalizumab in chronic urticaria refractory to conventional treatment (H1-antihistamines at high dosage and montelukast) in real-life practice. PATIENTS AND METHODS A retrospective, descriptive, single-centre study was performed of the data for all patients presenting refractory chronic spontaneous urticaria or inducible urticaria and receiving omalizumab (300mg every four weeks) from November 2012 to June 2016. RESULTS In all, 23 patients were included. Omalizumab led to complete or significant remission in 19 patients (83%) with chronic urticaria, with remission in 9 patients (47%) occurring within 72hours of the first injection. One patient had a partial response and 3 (13%) showed no response. Only 2 patients (9%) in complete remission stopped their treatment at 1 and 3 years. 52% of patients presented non-serious adverse events, which in one case resulted in treatment withdrawal. CONCLUSION Omalizumab exhibited good real-life efficacy in a small series of chronic urticaria patients in France.
Collapse
Affiliation(s)
- A Hamelin
- Service de dermatologie et allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France.
| | - E Amsler
- Service de dermatologie et allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
| | - P Mathelier-Fusade
- Service de dermatologie et allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
| | - C Pecquet
- Service de dermatologie et allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
| | - O Bayrou
- Service de dermatologie et allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
| | - A Barbaud
- Service de dermatologie et allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France; Faculté de médecine, Sorbonne université, 75006 Paris, France
| | - A Soria
- Service de dermatologie et allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France; Inserm U1135, Cimi-Paris, centre d'immunologie et de maladies infectieuses, 75013 Paris, France
| |
Collapse
|
35
|
de Risi-Pugliese T, Barailler H, Hamelin A, Amsler E, Gaouar H, Jullie ML, Barbaud A, Moguelet P, Milpied-Homsi B, Soria A. Caractéristiques cliniques, biologiques, histologiques et explorations allergologiques des SDRIFE, à partir d’une série de 20 cas. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
36
|
Kurihara F, De Risi-Pugliese T, Amsler E, Autegarden J, Bayrou O, Gaouar H, Pecquet C, Barbaud A, Soria A. Manifestations cutanées des antihistaminiques anti-H1. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
37
|
Assier H, Tetart F, Avenel-Audran M, Barbaud A, Ferrier-le Bouëdec MC, Giordano-Labadie F, Milpied B, Amsler E, Collet E, Girardin P, Soria A, Waton J, Truchetet F, Bourrain JL, Gener G, Bernier C, Raison-Peyron N. Is a specific eyelid patch test series useful? Results of a French prospective study. Contact Dermatitis 2018; 79:157-161. [PMID: 29882592 DOI: 10.1111/cod.13040] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Revised: 04/27/2018] [Accepted: 04/29/2018] [Indexed: 10/14/2022]
Abstract
BACKGROUND Eyelids are frequent sites of contact dermatitis. No prospective study focused on eyelid allergic contact dermatitis (EACD) has yet been published, and this topic has never been studied in French patients. OBJECTIVES To prospectively evaluate the usefulness of an eyelid series in French patients patch tested because of EACD, and to describe these patients. METHODS We prospectively analysed standardized data for all patients referred to our departments between September 2014 and August 2016 for patch testing for suspected EACD as the main reason. All patients were patch tested with an eyelid series, the European baseline series (EBS), the French additional series, and their personal products. Patch testing with additional series and repeated open application tests (ROATs) or open tests were performed if necessary. A standardized assessment of the relevance was used, and the analysis of the results was focused on patients having positive test results with a current certain relevance. RESULTS Two-hundred and sixty-four patients (238 women and 26 men) were included. Three-hundred and twenty-two tests gave positive results in 167 patients, 84 of whom had currently relevant reactions: 56 had currently relevant positive test reactions to the EBS, 16 had currently relevant positive test reactions to their personal products, 8 had currently relevant positive test reactions to the French additional series, and 4 had currently relevant positive test reactions to the eyelid series. Sixty-seven per cent of all relevant cases were related to cosmetic products. The most frequent allergens with current relevance were methylisothiazolinone (10.2%), fragrance mix I (3%), nickel (2.7%), hydroxyperoxides of linalool (2.7%) and limonene (2.3%), and Myroxylon pereirae (2.3%). Current atopic dermatitis was found in 9.5% of patients. The duration of dermatitis was shorter (23.2 vs 34.2 months; P = .035) in patients with currently relevant test reactions. The percentage of currently relevant tests remained the same when atopic patients or dermatitis localized only on the eyelids were taken into account. CONCLUSION In French patients, testing for EACD with the extended baseline series and personal products, also including ROATs and use tests, appears to be adequate, considering the currently relevant positive test reactions. The regular addition of an eyelid series does not seem to be necessary.
Collapse
Affiliation(s)
- Haudrey Assier
- Department of Dermatology, CHU Henri-Mondor, Créteil, France
| | | | | | - Annick Barbaud
- Department of Dermatology and Allergy, Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | | | | | | | - Emmanuelle Amsler
- Department of Dermatology and Allergy, Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | - Evelyne Collet
- Department of Dermatology, Hôpital le Bocage, Dijon, France
| | | | - Angèle Soria
- Department of Dermatology and Allergy, Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | - Julie Waton
- Department of Dermatology, CHRU Nancy, Nancy, France
| | | | | | | | | | | | | |
Collapse
|
38
|
de Risi-Pugliese T, Amsler E, Collet E, Francès C, Barbaud A, Pecquet C, Soria A. Eyelid allergic contact dermatitis after intravitreal injections of anti-vascular endothelial growth factor: What is the culprit? A report of 3 cases. Contact Dermatitis 2018; 79:103-104. [PMID: 29708276 DOI: 10.1111/cod.13000] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2018] [Accepted: 02/28/2018] [Indexed: 11/29/2022]
Affiliation(s)
| | - Emmanuelle Amsler
- AP-HP, Dermatology and Allergology Department, Hôpital Tenon, Paris, France
| | - Evelyne Collet
- Dermatology Department, Hôpital le Bocage, Dijon, France
| | - Camille Francès
- AP-HP, Dermatology and Allergology Department, Hôpital Tenon, Paris, France.,Faculty of Medicine, Sorbonne Université, Paris, France
| | - Annick Barbaud
- AP-HP, Dermatology and Allergology Department, Hôpital Tenon, Paris, France.,Faculty of Medicine, Sorbonne Université, Paris, France
| | - Catherine Pecquet
- AP-HP, Dermatology and Allergology Department, Hôpital Tenon, Paris, France
| | - Angèle Soria
- AP-HP, Dermatology and Allergology Department, Hôpital Tenon, Paris, France.,Faculty of Medicine, Sorbonne Université, Paris, France.,Immunology and Infectious Diseases Department (Cimi-Paris), Inserm 1135, Paris, France
| |
Collapse
|
39
|
Soria A, Du-Thanh A, Amsler E, Raison-Peyron N, Mathelier-Fusade P, Staumont-Sallé D, Hacard F, Boccon-Gibod I, Castela E, Pralong P, Doutre MS, Puymirat E. Obesity is not associated with severe chronic urticaria in a French cohort. J Eur Acad Dermatol Venereol 2018; 32:e247-e249. [DOI: 10.1111/jdv.14767] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Affiliation(s)
- A. Soria
- Service de Dermatologie et Allergologie; Hopital Tenon; Assistance Publique-Hôpitaux de Paris; Paris France
- Immunology and Infectious Diseases Center - Paris (Cimi-Paris); UPMC Univ Paris 06; Sorbonne Université; Paris France
- INSERM U1135; Paris France
| | - A. Du-Thanh
- Service de Dermatologie; Hôpital Saint-Eloi; CHU de Montpellier; Montpellier France
| | - E. Amsler
- Service de Dermatologie et Allergologie; Hopital Tenon; Assistance Publique-Hôpitaux de Paris; Paris France
| | - N. Raison-Peyron
- Service de Dermatologie; Hôpital Saint-Eloi; CHU de Montpellier; Montpellier France
| | - P. Mathelier-Fusade
- Service de Dermatologie et Allergologie; Hopital Tenon; Assistance Publique-Hôpitaux de Paris; Paris France
| | | | - F. Hacard
- Centre Hospitalier Lyon-Sud; Service d'allergologie et d'immunologie clinique Pierre-Bénite; Hospices Civils de Lyon; Pierre-Bénite France
| | - I. Boccon-Gibod
- Centre de référence National de l'angioedème; CHU de Grenoble; Clinique Universitaire de Médecine Interne; Grenoble cedex 09 France
| | - E. Castela
- Service de Dermatologie; Hôpital Universitaire de Nice; Nice France
| | - P. Pralong
- Service de Dermatologie; CHU de Grenoble; Grenoble cedex 09 France
| | - M.-S. Doutre
- Service de Dermatologie; Hopital Saint-André; Bordeaux France
| | - E. Puymirat
- Department of Cardiology; Hôpital Européen Georges Pompidou (HEGP); Assistance Publique-Hôpitaux de Paris (AP-HP); Paris France
- Université Paris-Descartes; Paris France
| | | |
Collapse
|
40
|
Assier H, Tetart F, Ferrier-le Bouëdec MC, Giordano-Labadie F, Milpied B, Avenel-Audran M, Collet E, Girardin P, Soria A, Amsler E, Barbaud A, Waton J, Truchetet F, Bourrain J, Gener G, Bernier C, Raison-Peyron N. Évaluation d’une batterie spécifique de patch-tests pour l’enquête allergologique des eczémas des paupières : étude prospective française du DAG. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
41
|
De Risi-Pugliese T, Amsler E, Francès C, Barbaud A, Soria A, Pecquet C. Eczémas des paupières à l’azithromycine collyre au cours d’injections intra-vitréennes pour DMLA. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
42
|
Soria A, Raison-Peyron N, Amsler E, Du-Thanh A, Mathelier-Fusade P, Staumont-Sallé D, Hacard F, Boccon-Gibod I, Castela E, Doutre MS. Urticaire chronique et obésité : quels liens ? Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
43
|
Abstract
BACKGROUND About 10% of subjects report suspected penicillin allergy, but 85-90% of these patients are not truly allergic and could safely receive beta-lactam antibiotics Objective: To design and validate a clinical decision-making algorithm, based on anamnesis (chronology, severity, and duration of the suspected allergic reactions) and reaching a 100% sensitivity and negative predictive value, to assess allergy risk related to a penicillin prescription in general practise. STUDY DESIGN AND METHODS All patients were included prospectively and explorated based on ENDA/EAACI recommendations. Results of penicillin allergy work-up (gold standard) were compared with results of the algorithm. RESULTS Allergological work-up diagnosed penicillin hypersensitivity in 41/259 patients (15.8%) [95% CI: 11.5-20.3]. Three of these patients were diagnosed as having immediate-type hypersensitivity to penicillin, but had been misdiagnosed as low risk patients using the clinical algorithm. Thus, the sensitivity and negative predictive value of the algorithm were 92.7% [95% CI: 80.1-98.5] and 96.3% [95% CI: 89.6-99.2], respectively, and the probability that a patient with true penicillin allergy had been misclassified was 3.7% [95% CI: 0.8-10.4]. CONCLUSIONS Although the risk of misclassification is low, we cannot recommend the use of this algorithm in general practice. However, the algorithm can be useful in emergency situations in hospital settings. Key messages True penicillin allergy is considerably lower than alleged penicillin allergy (15.8%; 41 of the 259 patients with suspected penicillin allergy). A clinical algorithm based on the patient's clinical history of the supposed allergic event to penicillin misclassified 3/41 (3.7%) truly allergic patients.
Collapse
Affiliation(s)
- Angèle Soria
- a Department of Dermatology and Allergology , Tenon Hospital, APHP , Paris , France.,b Immunology and Infectious diseases Center - Paris (Cimi-Paris) , Sorbonne University , Paris , France.,c INSERM U1135, Cimi-Paris , Paris , France
| | - Elodie Autegarden
- a Department of Dermatology and Allergology , Tenon Hospital, APHP , Paris , France
| | - Emmanuelle Amsler
- a Department of Dermatology and Allergology , Tenon Hospital, APHP , Paris , France
| | - Hafida Gaouar
- a Department of Dermatology and Allergology , Tenon Hospital, APHP , Paris , France
| | - Amandine Vial
- a Department of Dermatology and Allergology , Tenon Hospital, APHP , Paris , France
| | - Camille Francès
- a Department of Dermatology and Allergology , Tenon Hospital, APHP , Paris , France
| | - Jean-Eric Autegarden
- a Department of Dermatology and Allergology , Tenon Hospital, APHP , Paris , France
| |
Collapse
|
44
|
Raison-Peyron N, Amsler E, Pecquet C, Du-Thanh A, Naessens T, Apers S, Aerts O. Severe allergic contact dermatitis caused by octylisothiazolinone in a leather sofa: two new cases. Contact Dermatitis 2017; 77:176-178. [DOI: 10.1111/cod.12793] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2017] [Accepted: 02/11/2017] [Indexed: 11/29/2022]
Affiliation(s)
- Nadia Raison-Peyron
- Department of Dermatology; Hôpital Saint-Eloi, CHU de Montpellier; 34295 Montpellier France
| | - Emmanuelle Amsler
- Dermatology and Allergology Department; Tenon Hospital (AP-HP), Sorbonne Universities, UPMC University Paris 06; 75020 Paris France
| | - Catherine Pecquet
- Dermatology and Allergology Department; Tenon Hospital (AP-HP), Sorbonne Universities, UPMC University Paris 06; 75020 Paris France
| | - Aurélie Du-Thanh
- Department of Dermatology; Hôpital Saint-Eloi, CHU de Montpellier; 34295 Montpellier France
| | - Tania Naessens
- Research Group Natural Products and Food - Research and Analysis (NatuRA), Department of Pharmaceutical Sciences; University of Antwerp (UA); 2610 Antwerp Belgium
| | - Sandra Apers
- Research Group Natural Products and Food - Research and Analysis (NatuRA), Department of Pharmaceutical Sciences; University of Antwerp (UA); 2610 Antwerp Belgium
| | - Olivier Aerts
- Department of Dermatology; University Hospital Antwerp (UZA) and University of Antwerp (UA); 2650 Antwerp Belgium
| |
Collapse
|
45
|
Abstract
Allergy to beta-lactam antibiotics is a common condition and about 10% of patients report being allergic to penicillin. However, this diagnosis is largely overestimated. Two types of allergy should be distinguished and include immediate hypersensitivity that can lead to anaphylactic shock and delayed hypersensitivity, ranging from the most common maculopapular exanthema to severe bullous toxidermia or life-threatening DRESS. Allergy challenge with oriented skin tests according to the clinical features, supplemented with oral challenge in the absence of contraindication, will confirm or invalidate the diagnosis of beta-lactam allergy and will help to identify if necessary safe alternatives to beta-lactams.
Collapse
Affiliation(s)
- E Amsler
- Service de dermatologie et allergologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
| | - A Soria
- Service de dermatologie et allergologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm U1135, immunology and infectious diseases center-Paris (Cimi-Paris), Sorbonne université, UPMC université Paris 06, 75013 Paris, France
| |
Collapse
|
46
|
Amsler E, Al-Raddadi R, Frances C. Allergic contact dermatitis caused by PEG-22/dodecyl glycol copolymer in a skin-repairing cream. Contact Dermatitis 2017; 77:54-55. [DOI: 10.1111/cod.12743] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2016] [Revised: 11/08/2016] [Accepted: 11/10/2016] [Indexed: 11/29/2022]
Affiliation(s)
- Emmanuelle Amsler
- Department of dermatology and allergology; Tenon Hospital; 75020 Paris France
| | - Reem Al-Raddadi
- Department of dermatology and allergology; Tenon Hospital; 75020 Paris France
| | - Camille Frances
- Department of dermatology and allergology; Tenon Hospital; 75020 Paris France
| |
Collapse
|
47
|
Amsler E, Aerts O, Raison-Peyron N, Debons M, Milpied B, Giordano-Labadie F, Waton J, Ferrier-Le Bouëdec MC, Lartigau I, Pecquet C, Assier H, Avenel-Audran M, Bernier C, Castelain F, Collet E, Crépy MN, Genillier N, Girardin P, Pralong P, Tetart F, Vital-Durand D, Soria A, Barbaud A. Airborne allergic contact dermatitis caused by isothiazolinones in water-based paints: a retrospective study of 44 cases. Contact Dermatitis 2017; 77:163-170. [DOI: 10.1111/cod.12795] [Citation(s) in RCA: 47] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2016] [Revised: 02/12/2017] [Accepted: 02/13/2017] [Indexed: 11/30/2022]
Affiliation(s)
- Emmanuelle Amsler
- Dermatology and Allergology Department, Tenon Hospital (AP-HP); Sorbonne Universities, UPMC University Paris 06; 75020 Paris France
| | - Olivier Aerts
- Department of Dermatology; University Hospital Antwerp and University of Antwerp; Wilrijkstraat 10, 2650 Antwerp Belgium
| | | | | | - Brigitte Milpied
- Department of Dermatology; Saint André Hospital; 33000 Bordeaux France
| | | | - Julie Waton
- Dermatology and Allergy Department, Brabois Hospital; University Hospital of Nancy; 54500 Vandoeuvre les Nancy France
| | - Marie C. Ferrier-Le Bouëdec
- Department of Dermatology, CHU Clermont-Ferrand; University Clermont Auvergne; 63000 Clermont-Ferrand France
| | | | - Catherine Pecquet
- Dermatology and Allergology Department, Tenon Hospital (AP-HP); Sorbonne Universities, UPMC University Paris 06; 75020 Paris France
| | - Haudrey Assier
- Department of Dermatology; Henri Mondor Hospital; 94010 Créteil France
| | | | - Claire Bernier
- Department of Dermatology; Hôtel-Dieu Hospital; 44093 Nantes France
| | - Florence Castelain
- Department of Dermatology and Allergology, CHU Jean Minjoz; 25030 Besançon France
| | - Evelyne Collet
- Department of Dermatology; CHU-François Mitterand Hospital; 21000 Dijon France
| | | | | | - Pascal Girardin
- Department of Dermatology and Allergology, CHU Jean Minjoz; 25030 Besançon France
| | - Pauline Pralong
- Department of Dermatology, Allergology and Photobiology, CHU; 38700 Grenoble France
| | - Florence Tetart
- Department of Dermatology; Charles Nicolle Hospital; 76031 Rouen France
| | | | - Angele Soria
- Dermatology and Allergology Department, Tenon Hospital (AP-HP); Sorbonne Universities, UPMC University Paris 06; 75020 Paris France
| | - Annick Barbaud
- Dermatology and Allergology Department, Tenon Hospital (AP-HP); Sorbonne Universities, UPMC University Paris 06; 75020 Paris France
- Dermatology and Allergy Department, Brabois Hospital; University Hospital of Nancy; 54500 Vandoeuvre les Nancy France
| | | |
Collapse
|
48
|
Sesé L, Gaouar H, Autegarden JE, Alari A, Amsler E, Vial-Dupuy A, Pecquet C, Francès C, Soria A. Immediate hypersensitivity to iodinated contrast media: diagnostic accuracy of skin tests and intravenous provocation test with low dose. Clin Exp Allergy 2016; 46:472-8. [PMID: 26750091 DOI: 10.1111/cea.12703] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2015] [Revised: 12/01/2015] [Accepted: 01/01/2016] [Indexed: 11/29/2022]
Abstract
BACKGROUND The diagnosis of HSR to iodinated contrast media (ICM) is challenging based on clinical history and skin tests. OBJECTIVE This study evaluates the negative predictive value (NPV) of skin tests and intravenous provocation test (IPT) with low-dose ICM in patients with suspected immediate hypersensitivity reaction (HSR) to ICM. METHODS Thirty-seven patients with suspected immediate hypersensitivity reaction to ICM were included retrospectively. Skin tests and a single-blind placebo-controlled intravenous provocation test (IPT) with low-dose iodinated contrast media (ICM) were performed. RESULTS Skin tests with ICM were positive in five cases (one skin prick test and five intradermal test). Thirty-six patients were challenged successfully by IPT, and only one patient had a positive challenge result, with a grade I reaction by the Ring and Messmer classification. Ten of 23 patients followed up by telephone were re-exposed to a negative tested ICM during radiologic examination; two experienced a grade I immediate reaction. CONCLUSIONS & CLINICAL RELEVANCE For immediate hypersensitivity reaction to ICM, the NPV for skin tests and IPT with low dose was 80% (95% CI 44-97%).
Collapse
Affiliation(s)
- L Sesé
- Service de Dermatologie-Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France
| | - H Gaouar
- Service de Dermatologie-Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France
| | - J-E Autegarden
- Service de Dermatologie-Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France
| | - A Alari
- Inserm UMR 1181 Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Villejuif, Paris, France.,Institut Pasteur, UMR 1181, B2PHI, Paris, France
| | - E Amsler
- Service de Dermatologie-Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France
| | - A Vial-Dupuy
- Service de Dermatologie-Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France
| | - C Pecquet
- Service de Dermatologie-Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France
| | - C Francès
- Service de Dermatologie-Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France.,Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), UPMC Univ Paris 06, Sorbonne Universités, Paris, France.,Institut National de Santé et de Recherche Médicale (INSERM) U1135, Cimi-Paris, Paris, France
| | - A Soria
- Service de Dermatologie-Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France.,Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), UPMC Univ Paris 06, Sorbonne Universités, Paris, France.,Institut National de Santé et de Recherche Médicale (INSERM) U1135, Cimi-Paris, Paris, France
| |
Collapse
|
49
|
Amsler E, Autegarden JE, Senet P, Frances C, Soria A. [Recurrence of drug eruption after renewed injection of iodinated contrast medium in patients with known allergic contraindications]. Ann Dermatol Venereol 2016; 143:804-807. [PMID: 27473686 DOI: 10.1016/j.annder.2016.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2015] [Revised: 04/13/2016] [Accepted: 06/03/2016] [Indexed: 10/21/2022]
Abstract
BACKGROUND Iodinated contrast media (ICM) are used extensively by both radiologists and cardiologists. Injection of such products can induce immediate hypersensitivity reactions, some of which are IgE-mediated, and delayed hypersensitivity reaction with all types of drug eruptions being reported. Allergy tests, whether patch-tests or intradermal tests, are useful to confirm whether patients are allergic. At the end of these tests, depending on the reaction (chronology and clinical symptoms) and the results of the skin tests, patients are given an allergy card as well as a detailed certificate indicating the various ICM contraindicated and those allowed. OBSERVATIONS We report herein three cases of patients experiencing a confirmed allergic eruption after injection of ICM, and whose recommendations and contraindication were not taken into consideration, leading to recurrence of eruption after renewed ICM injection. DISCUSSION The three cases we report herein underscore the lack of knowledge concerning eruptions induced by ICM, particularly among radiologists. Better dissemination of information about the existence of such reactions appears necessary amongst the medical professionals concerned.
Collapse
Affiliation(s)
- E Amsler
- Service de dermatologie et allergologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
| | - J-E Autegarden
- Service de dermatologie et allergologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France
| | - P Senet
- Service de dermatologie et allergologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France
| | - C Frances
- Service de dermatologie et allergologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France
| | - A Soria
- Service de dermatologie et allergologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Immunology and infectious diseases center-Paris (Cimi-Paris), Inserm U1135, Sorbonne university, UPMC université Paris 06, 75013 Paris, France
| |
Collapse
|
50
|
Amsler E, Augey F, Soria A, Boccon-Gibod I, Doutre M, Mathelier-Fusade P, Nicolas J, Rayson-Peyron N, Gompel A. Chronic urticaria and hormones: Is there a link? J Eur Acad Dermatol Venereol 2016; 30:1527-30. [DOI: 10.1111/jdv.13644] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2015] [Accepted: 02/15/2016] [Indexed: 11/29/2022]
Affiliation(s)
- E. Amsler
- Service de Dermatologie-Allergologie; Hôpital Tenon; HUEP, APHP; Paris France
- GUS: Groupe Urticaire de la Société Française de Dermatologie; France
| | - F. Augey
- GUS: Groupe Urticaire de la Société Française de Dermatologie; France
- Université Lyon1; INSERM U1111 - CIRI; Hôpitaux de Lyon; CH Lyon-Sud; Lyon France
| | - A. Soria
- Service de Dermatologie-Allergologie; Hôpital Tenon; HUEP, APHP; Paris France
- GUS: Groupe Urticaire de la Société Française de Dermatologie; France
- Sorbonne Universités; UPMC Univ Paris 06; Unité Mixte de Recherche de Santé (UMR S) CR7; Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris); INSERM U1135; Paris France
| | - I. Boccon-Gibod
- GUS: Groupe Urticaire de la Société Française de Dermatologie; France
- Clinique Universitaire de Médecine Interne; CHU de Grenoble; Grenoble Cedex France
- Centre National de Référence des Angiœdèmes (CRéAK); France
| | - M.S. Doutre
- GUS: Groupe Urticaire de la Société Française de Dermatologie; France
- Service de Dermatologie; Hôpital Saint-André; CHU de Bordeaux; Bordeaux France
| | - P. Mathelier-Fusade
- Service de Dermatologie-Allergologie; Hôpital Tenon; HUEP, APHP; Paris France
- GUS: Groupe Urticaire de la Société Française de Dermatologie; France
| | - J.F. Nicolas
- GUS: Groupe Urticaire de la Société Française de Dermatologie; France
- Université Lyon1; INSERM U1111 - CIRI; Hôpitaux de Lyon; CH Lyon-Sud; Lyon France
| | - N. Rayson-Peyron
- GUS: Groupe Urticaire de la Société Française de Dermatologie; France
- Centre National de Référence des Angiœdèmes (CRéAK); France
- Service de Dermatologie; hôpital St Eloi; Montpellier Cedex France
| | - A. Gompel
- GUS: Groupe Urticaire de la Société Française de Dermatologie; France
- Centre National de Référence des Angiœdèmes (CRéAK); France
- Unité de Gynécologie Endocrinienne; Université Paris Descartes; APHP, Port Royal Cochin; Paris France
| |
Collapse
|